Wei-Ping Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wei-Ping Yu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Amaury Cazenave-Gassiot
Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Singapore
1 shared publication Chen Bai
Singapore-HUJ Alliance for Research and Enterprise, Molecular Mechanisms of Inflammatory Diseases Program, National University of Singapore, 138602, Singapore
1 shared publication- Chen Chen
School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia
1 shared publication - Chew Kiat Matthew Heng
Department of Microbiology & Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore-HUJ Alliance for Research and Enterprise, Mechanisms of Liver Inflammatory Diseases Program, National University of Singapore, Singapore
1 shared publication Daniel G. Chain
CereSpir Incorporated, New York, NY 10010, USA
1 shared publication- David Engelberg
Department of Biological Chemistry, The Institute of Life Science, The Hebrew University of Jerusalem, Jerusalem 91904, Israel
1 shared publication
Latest Publications
- 23 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 15 (748) , eabk3411
The APP intracellular domain promotes LRRK2 expression to enable feed-forward neurodegenerative mechanisms in Parkinson’s disease
Gain-of-function mutations in the leucine-rich repeat kinase 2 ( LRRK2 ) gene are common in familial forms of Parkinson’s disease (PD), which is characterized by progressive neurodegeneration that impairs motor and cognitive function. We previously demonstrated that LRRK2-mediated phosphorylation of β-amyloid precursor protein (APP) triggers the production and nuclear translocation of the APP intracellular domain (AICD). Here, we connected LRRK2 to AICD in a feed-forward cycle that enhanced LRRK2-mediated neurotoxicity. In cooperation with the transcription factor FOXO3a, AICD promoted LRRK2 expression, thus increasing the abundance of LRRK2 that promotes AICD activation. APP deficiency in LRRK2 G2019S mice suppressed LRRK2 expression, LRRK2-mediated mitochondrial dysfunction, α-synuclein accumulation, and tyrosine hydroxylase (TH) loss in the brain, phenotypes associated with toxicity and loss of dopaminergic neurons in PD. Conversely, AICD overexpression increased LRRK2 expression and LRRK2-mediated neurotoxicity in LRRK2 G2019S mice. In LRRK2 G2019S mice or cultured dopaminergic neurons from LRRK2 G2019S patients, treatment with itanapraced reduced LRRK2 expression and was neuroprotective. Itanapraced showed similar effects in a neurotoxin-induced PD mouse model, suggesting that inhibiting the AICD may also have therapeutic benefits in idiopathic PD. Our findings reveal a therapeutically targetable, feed-forward mechanism through which AICD promotes LRRK2-mediated neurotoxicity in PD.
- 23 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 15 (748) , eabk3411
The APP intracellular domain promotes LRRK2 expression to enable feed-forward neurodegenerative mechanisms in Parkinson’s disease
Gain-of-function mutations in the leucine-rich repeat kinase 2 ( LRRK2 ) gene are common in familial forms of Parkinson’s disease (PD), which is characterized by progressive neurodegeneration that impairs motor and cognitive function. We previously demonstrated that LRRK2-mediated phosphorylation of β-amyloid precursor protein (APP) triggers the production and nuclear translocation of the APP intracellular domain (AICD). Here, we connected LRRK2 to AICD in a feed-forward cycle that enhanced LRRK2-mediated neurotoxicity. In cooperation with the transcription factor FOXO3a, AICD promoted LRRK2 expression, thus increasing the abundance of LRRK2 that promotes AICD activation. APP deficiency in LRRK2 G2019S mice suppressed LRRK2 expression, LRRK2-mediated mitochondrial dysfunction, α-synuclein accumulation, and tyrosine hydroxylase (TH) loss in the brain, phenotypes associated with toxicity and loss of dopaminergic neurons in PD. Conversely, AICD overexpression increased LRRK2 expression and LRRK2-mediated neurotoxicity in LRRK2 G2019S mice. In LRRK2 G2019S mice or cultured dopaminergic neurons from LRRK2 G2019S patients, treatment with itanapraced reduced LRRK2 expression and was neuroprotective. Itanapraced showed similar effects in a neurotoxin-induced PD mouse model, suggesting that inhibiting the AICD may also have therapeutic benefits in idiopathic PD. Our findings reveal a therapeutically targetable, feed-forward mechanism through which AICD promotes LRRK2-mediated neurotoxicity in PD.
- Open Access
- 1 August 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (32)
Loss of Ca V 1.3 RNA editing enhances mouse hippocampal plasticity, learning, and memory
L-type Ca V 1.3 calcium channels are expressed on the dendrites and soma of neurons, and there is a paucity of information about its role in hippocampal plasticity. Here, by genetic targeting to ablate Ca V 1.3 RNA editing, we demonstrate that unedited Ca V 1.3 ΔECS mice exhibited improved learning and enhanced long-term memory, supporting a functional role of RNA editing in behavior. Significantly, the editing paradox that functional recoding of Ca V 1.3 RNA editing sites slows Ca 2+ -dependent inactivation to increase Ca 2+ influx but reduces channel open probability to decrease Ca 2+ influx was resolved. Mechanistically, using hippocampal slice recordings, we provide evidence that unedited Ca V 1.3 channels permitted larger Ca 2+ influx into the hippocampal pyramidal neurons to bolster neuronal excitability, synaptic transmission, late long-term potentiation, and increased dendritic arborization. Of note, RNA editing of the Ca V 1.3 IQ-domain was found to be evolutionarily conserved in mammals, which lends support to the importance of the functional recoding of the Ca V 1.3 channel in brain function.
- 1 August 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (32)
Open AccessLoss of Ca V 1.3 RNA editing enhances mouse hippocampal plasticity, learning, and memory
L-type Ca V 1.3 calcium channels are expressed on the dendrites and soma of neurons, and there is a paucity of information about its role in hippocampal plasticity. Here, by genetic targeting to ablate Ca V 1.3 RNA editing, we demonstrate that unedited Ca V 1.3 ΔECS mice exhibited improved learning and enhanced long-term memory, supporting a functional role of RNA editing in behavior. Significantly, the editing paradox that functional recoding of Ca V 1.3 RNA editing sites slows Ca 2+ -dependent inactivation to increase Ca 2+ influx but reduces channel open probability to decrease Ca 2+ influx was resolved. Mechanistically, using hippocampal slice recordings, we provide evidence that unedited Ca V 1.3 channels permitted larger Ca 2+ influx into the hippocampal pyramidal neurons to bolster neuronal excitability, synaptic transmission, late long-term potentiation, and increased dendritic arborization. Of note, RNA editing of the Ca V 1.3 IQ-domain was found to be evolutionarily conserved in mammals, which lends support to the importance of the functional recoding of the Ca V 1.3 channel in brain function.
- 2 April 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (14)
Active p38α causes macrovesicular fatty liver in mice
One third of the western population suffers from nonalcoholic fatty liver disease (NAFLD), which may ultimately develop into hepatocellular carcinoma (HCC). The molecular event(s) that triggers the disease are not clear. Current understanding, known as the multiple hits model, suggests that NAFLD is a result of diverse events at several tissues (e.g., liver, adipose tissues, and intestine) combined with changes in metabolism and microbiome. In contrast to this prevailing concept, we report that fatty liver could be triggered by a single mutated protein expressed only in the liver. We established a transgenic system that allows temporally controlled activation of the MAP kinase p38α in a tissue-specific manner by induced expression of intrinsically active p38α allele. Here we checked the effect of exclusive activation in the liver. Unexpectedly, induction of p38α alone was sufficient to cause macrovesicular fatty liver. Animals did not become overweight, showing that fatty liver can be imposed solely by a genetic modification in liver per se and can be separated from obesity. Active p38α-induced fatty liver is associated with up-regulation of MUC13, CIDEA, PPARγ, ATF3, and c-jun mRNAs, which are up-regulated in human HCC. Shutting off expression of the p38α mutant resulted in reversal of symptoms. The findings suggest that p38α plays a direct causative role in fatty liver diseases and perhaps in other chronic inflammatory diseases. As p38α activity was induced by point mutations, it could be considered a proto-inflammatory gene (proto-inflammagene). Significance While the MAPK p38α is highly active in nonalcoholic fatty liver disease (NAFLD), whether its constitutive activity is a driver or mere consequence of pathology remains unclear. This was not answered due to the lack of methods for specific p38α activation in vivo. A transgenic mouse model allowing inducible expression of an intrinsically active p38α variant in a tissue-specific manner meets this challenge. Upon expression of the active p38α allele in the liver, mice develop lipidosis (fatty liver) within four weeks without gaining overweight. This study shows that fatty liver could occur in response to activation of a single protein and provides the first genetic model for revealing the etiology of fatty liver diseases from the point of their trigger.
- 2 April 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (14)
Active p38α causes macrovesicular fatty liver in mice
One third of the western population suffers from nonalcoholic fatty liver disease (NAFLD), which may ultimately develop into hepatocellular carcinoma (HCC). The molecular event(s) that triggers the disease are not clear. Current understanding, known as the multiple hits model, suggests that NAFLD is a result of diverse events at several tissues (e.g., liver, adipose tissues, and intestine) combined with changes in metabolism and microbiome. In contrast to this prevailing concept, we report that fatty liver could be triggered by a single mutated protein expressed only in the liver. We established a transgenic system that allows temporally controlled activation of the MAP kinase p38α in a tissue-specific manner by induced expression of intrinsically active p38α allele. Here we checked the effect of exclusive activation in the liver. Unexpectedly, induction of p38α alone was sufficient to cause macrovesicular fatty liver. Animals did not become overweight, showing that fatty liver can be imposed solely by a genetic modification in liver per se and can be separated from obesity. Active p38α-induced fatty liver is associated with up-regulation of MUC13, CIDEA, PPARγ, ATF3, and c-jun mRNAs, which are up-regulated in human HCC. Shutting off expression of the p38α mutant resulted in reversal of symptoms. The findings suggest that p38α plays a direct causative role in fatty liver diseases and perhaps in other chronic inflammatory diseases. As p38α activity was induced by point mutations, it could be considered a proto-inflammatory gene (proto-inflammagene). Significance While the MAPK p38α is highly active in nonalcoholic fatty liver disease (NAFLD), whether its constitutive activity is a driver or mere consequence of pathology remains unclear. This was not answered due to the lack of methods for specific p38α activation in vivo. A transgenic mouse model allowing inducible expression of an intrinsically active p38α variant in a tissue-specific manner meets this challenge. Upon expression of the active p38α allele in the liver, mice develop lipidosis (fatty liver) within four weeks without gaining overweight. This study shows that fatty liver could occur in response to activation of a single protein and provides the first genetic model for revealing the etiology of fatty liver diseases from the point of their trigger.
- Open Access
Towards Resolving the Challenge of Long-tail Distribution in UAV Images for Object Detection
Existing methods for object detection in UAV images ignored an important challenge - imbalanced class distribution in UAV images - which leads to poor performance on tail classes. We systematically investigate existing solutions to long-tail problems and unveil that re-balancing methods that are effective on natural image datasets cannot be trivially applied to UAV datasets. To this end, we rethink long-tailed object detection in UAV images and propose the Dual Sampler and Head detection Network (DSHNet), which is the first work that aims to resolve long-tail distribution in UAV images. The key components in DSHNet include Class-Biased Samplers (CBS) and Bilateral Box Heads (BBH), which are developed to cope with tail classes and head classes in a dual-path manner. Without bells and whistles, DSHNet significantly boosts the performance of tail classes on different detection frameworks. Moreover, DSHNet significantly outperforms base detectors and generic approaches for long-tail problems on VisDrone and UAVDT datasets. It achieves new state-of-the-art performance when combining with image cropping methods. Code is available at https://github.com/we1pingyu/DSHNet
Open AccessTowards Resolving the Challenge of Long-tail Distribution in UAV Images for Object Detection
Existing methods for object detection in UAV images ignored an important challenge - imbalanced class distribution in UAV images - which leads to poor performance on tail classes. We systematically investigate existing solutions to long-tail problems and unveil that re-balancing methods that are effective on natural image datasets cannot be trivially applied to UAV datasets. To this end, we rethink long-tailed object detection in UAV images and propose the Dual Sampler and Head detection Network (DSHNet), which is the first work that aims to resolve long-tail distribution in UAV images. The key components in DSHNet include Class-Biased Samplers (CBS) and Bilateral Box Heads (BBH), which are developed to cope with tail classes and head classes in a dual-path manner. Without bells and whistles, DSHNet significantly boosts the performance of tail classes on different detection frameworks. Moreover, DSHNet significantly outperforms base detectors and generic approaches for long-tail problems on VisDrone and UAVDT datasets. It achieves new state-of-the-art performance when combining with image cropping methods. Code is available at https://github.com/we1pingyu/DSHNet